Celltrion
Manufacturing · South Korea · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
23 Academy-ro Yeonsu-gu, Incheon, Gyeong...Phone Number
+82 328505000Website
www.celltrion.comRevenue
$3 BillionStock Symbol
91990Industry
About Celltrion
Headquartered in Incheon, Korea, Celltrion is a leading biopharmaceutical company, specializing in research, development and manufacturing of biosimilar and innovative drugs. Celltrion strives to provide more affordable biosimilar mAbs to patients who previously had limited access to advanced therapeutics. Celltrion received FDA and EC's approval for Inflectra® and Remsima®, respectively, which is the world's first mAb biosimilar to receive approval from a regulatory agency in a developed country.Explore more
Celltrion Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Celltrion
Compare insights from companies similar to Celltrion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Celltrion
$3B
1K - 5K
Public
-
2002
JS
Jiyun SeolChief Marketing Officer & Head of Operations Department
$843.9M
1K - 5K
Private
-
2007
MP
Melissa Pickell-MattsonProgram Director, Human Resources & Chief of Staff
Celltrion Tech Stack
A closer look at the technologies used by Celltrion
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Celltrion
Sign Up For FreeTo access detailed company insights
Headquartered in Incheon, Korea, Celltrion is a leading biopharmaceutical company, specializing in research, development and manufacturing of biosimilar and innovative drugs. Celltrion strives to provide more affordable biosimilar mAbs to patients who previously had limited access to advanced therapeutics. Celltrion received FDA and EC's approval f... Read More
